Stay updated on Amifampridine in MuSK-MG Clinical Trial

Sign up to get notified when there's something new on the Amifampridine in MuSK-MG Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amifampridine in MuSK-MG Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now presents a single 'Locations' section listing Ohio and Pennsylvania, replacing the separate 'Ohio Locations' and 'Pennsylvania Locations' entries. The 'HHS Vulnerability Disclosure' footer link was removed and the page revision updated to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T13:38:53.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision history updated: added v3.3.2 and removed v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T17:54:41.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The government funding/operating status notice at the top of the page has been removed.
    Difference
    0.4%
    Check dated 2025-11-17T17:46:12.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Minor UI and layout updates observed on the Study Details page, with no changes to core content such as the study title, eligibility criteria, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T12:30:26.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    - Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.
    Difference
    4%
    Check dated 2025-10-05T16:44:35.000Z thumbnail image
  9. Check
    105 days ago
    Change Detected
    Summary
    Added a new version label (v3.1.0) and removed several safety-focused topics (drug safety, counterfeit drugs, pharmaceutical preparations, substandard drugs), indicating a shift in page scope away from those subjects.
    Difference
    0.5%
    Check dated 2025-09-28T09:57:27.000Z thumbnail image

Stay in the know with updates to Amifampridine in MuSK-MG Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amifampridine in MuSK-MG Clinical Trial page.